Specialty Pharmaceuticals Industry Financials, Performance and Ratios
-
Industry Score
36.4 /100
Rank 98 out of 131 Industries -
Advance/Decline
13/11
-
No. of Companies24
-
Avg. Market Cap1,953
-
Price to Earning Ratio32.72
-
Price to Earning Growth Ratio0.11
-
Price to Book Ratio7.00
-
Return on Equity17.04
-
Return on Capital Employed-
-
Return on Assets14.97
-
Dividend yield 1 year %0.00
-
Net Profit Growth Annual YoY %85.85 %
-
Net Profit Growth Qtr YoY %72.94 %
-
Net Profit Growth Qtr QoQ %-110.01 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Specialty Pharmaceuticals Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Specialty Pharmaceuticals Peer comparison
Compare all stocks in Specialty Pharmaceuticals industry listed on stock exchanges
Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
---|---|---|---|---|---|---|---|---|---|---|---|
Usana Health Sciences Inc |
|
540.1
|
29
|
L
 -0.8%
H
28.9
29.1
|
L
 -1.4%
H
28.9
30.5
|
L
 -1.5%
H
27.8
31.5
|
L
 -2.0%
H
23.1
33.9
|
L
 -39.1%
H
23.1
49.2
|
L
 -60.1%
H
23.1
76.6
|
L
 -65.4%
H
23.1
107.9
|
L
 -55.9%
H
23.1
138.0
|
Argen X SE - ADR |
|
35,057.3
|
574.2
|
L
 -1.8%
H
570.0
579.9
|
L
 -2.3%
H
566.3
595.0
|
L
 -11.6%
H
529.1
657.4
|
L
 -8.1%
H
519.8
657.4
|
L
 54.8%
H
368.7
678.2
|
L
 82.1%
H
311.9
678.2
|
L
 146.7%
H
210.4
678.2
|
L
H
17.3
678.2
|
Biondvax Pharmaceuticals L... |
|
-
|
2.5
|
L
 -8.1%
H
2.5
2.7
|
L
 -9.4%
H
2.5
2.9
|
L
 -14.1%
H
2.5
3.0
|
L
 -14.1%
H
2.5
3.0
|
L
 -14.1%
H
2.5
3.0
|
L
 -81.1%
H
0.6
99
|
L
 -98.8%
H
0.6
620
|
L
 -94.1%
H
0.6
620
|
Cidara Therapeutics Inc |
|
292.9
|
22.6
|
L
 -0.4%
H
22.6
23.2
|
L
 -7%
H
21.5
24.9
|
L
 4.1%
H
18.5
27.6
|
L
 -9.3%
H
15.2
27.6
|
L
 77.9%
H
10.1
28.4
|
L
 -86.9%
H
10
840
|
L
 -98.5%
H
10
1780
|
L
 -99.7%
H
10
7228
|
Niagen Bioscience Inc. |
|
924.0
|
11.7
|
L
 8.4%
H
10.8
11.8
|
L
 18.7%
H
10.1
11.8
|
L
 46.6%
H
8.0
11.8
|
L
 108.0%
H
5.3
11.8
|
L
 325%
H
2.3
11.8
|
L
 523.9%
H
1.2
11.8
|
L
 148.0%
H
1.2
23.7
|
L
 225.8%
H
1.2
23.7
|
Cronos Group Inc |
|
743.9
|
1.9
|
L
 0.5%
H
1.9
1.9
|
L
 -4.9%
H
1.9
2.1
|
L
 4.9%
H
1.8
2.2
|
L
 -5.9%
H
1.6
2.2
|
L
 -25.5%
H
1.6
2.6
|
L
 -35.0%
H
1.6
3.6
|
L
 -70.0%
H
1.6
15.8
|
L
H
0.2
25.1
|
Enveric Biosciences Inc |
|
3.1
|
1.3
|
L
 1.6%
H
1.2
1.3
|
L
 -2.3%
H
1.1
1.3
|
L
 -3.1%
H
1.1
1.5
|
L
 -55.4%
H
1.0
2.9
|
L
 60.3%
H
0.3
4.8
|
L
 -88.4%
H
0.3
18.5
|
L
 -99.8%
H
0.3
752
|
L
 -100.0%
H
0.3
67500
|
Flora Growth Corp |
|
14.4
|
0.6
|
L
H
0.6
0.7
|
L
 -8.6%
H
0.6
0.7
|
L
 1.6%
H
0.5
0.8
|
L
 -15.8%
H
0.4
0.8
|
L
 -44.4%
H
0.4
2.1
|
L
 -96.6%
H
0.4
25.4
|
L
H
0.4
429
|
L
H
0.4
429
|
IM Cannabis Corp |
|
10.6
|
3.4
|
L
 -1.7%
H
3.1
3.7
|
L
 79.1%
H
1.8
7.1
|
L
 97.7%
H
1.5
7.1
|
L
 65.2%
H
1.3
7.1
|
L
H
0.4
7.1
|
L
 -94.2%
H
0.4
60.6
|
L
 -97.2%
H
0.4
697.8
|
L
H
0.4
697.8
|
Lifevantage Corporation |
|
160.2
|
12.7
|
L
 2.3%
H
12.5
12.9
|
L
 0.6%
H
12.1
13.5
|
L
 6.9%
H
9.8
13.7
|
L
 -25.9%
H
9.8
17.6
|
L
 67.3%
H
5.2
27.4
|
L
 196.0%
H
3.0
27.4
|
L
 -15.6%
H
3.0
27.4
|
L
 188.7%
H
1.4
27.4
|
Mannatech Inc |
|
20.1
|
10.6
|
L
 6.1%
H
10.0
10.7
|
L
 11.6%
H
9.5
10.7
|
L
 2.8%
H
9.0
12.0
|
L
 -6.2%
H
7.7
12.3
|
L
 37.0%
H
6.8
16.5
|
L
 -57.4%
H
6.8
28.0
|
L
 -34.1%
H
6.8
49.1
|
L
 -47.7%
H
6.5
49.1
|
Natural Alternatives Inter... |
|
20.6
|
3.3
|
L
H
3.3
3.3
|
L
 -0.6%
H
3.2
3.4
|
L
 12.5%
H
2.7
3.4
|
L
 -16.5%
H
2.6
4.0
|
L
 -48.4%
H
2.6
6.9
|
L
 -68.1%
H
2.6
12.6
|
L
 -50.8%
H
2.6
19.9
|
L
 -41.0%
H
2.6
19.9
|
Nature`s Sunshine Products... |
|
255.4
|
13.9
|
L
 -0.9%
H
13.9
14.6
|
L
 -2.5%
H
13.3
15.6
|
L
 11.5%
H
12.2
15.6
|
L
 -4.5%
H
11.0
15.6
|
L
 -9.1%
H
10.8
18.1
|
L
 13.5%
H
7.9
21.7
|
L
 48.7%
H
7.6
21.7
|
L
 9.6%
H
5.5
21.7
|
Paranovus Entertainment Te... |
|
67.3
|
1
|
L
H
1.0
1
|
L
H
0.9
1.0
|
L
 -22.5%
H
0.9
1.3
|
L
 -28.1%
H
0.9
1.5
|
L
 -2.0%
H
0.3
1.5
|
L
 -71.3%
H
0.3
6.7
|
L
 -98.2%
H
0.3
65
|
L
H
0.3
122
|
PharmaCyte Biotech Inc |
|
7.6
|
1.1
|
L
 3.7%
H
1.1
1.1
|
L
 5.7%
H
1
1.1
|
L
 -8.3%
H
1
1.4
|
L
 -36.9%
H
1
1.8
|
L
 -43.4%
H
1
2.4
|
L
 -50.9%
H
1
3.2
|
L
 -96%
H
1
55.5
|
L
 -99.5%
H
1
253.4
|
ProPhase Labs Inc |
|
16.2
|
0.4
|
L
 5.4%
H
0.4
0.4
|
L
 21.9%
H
0.3
0.4
|
L
 18.2%
H
0.2
0.5
|
L
 -13.3%
H
0.2
0.6
|
L
 -92.4%
H
0.2
5.2
|
L
 -96.0%
H
0.2
15.3
|
L
 -74.3%
H
0.2
16.0
|
L
 -70.7%
H
0.2
16.0
|
Qualigen Therapeutics Inc |
|
2.9
|
3.9
|
L
H
3.8
4.0
|
L
 4.0%
H
3.7
4.0
|
L
 12%
H
3.4
4.1
|
L
 23.7%
H
2.9
4.4
|
L
 -71.0%
H
0.1
29.4
|
L
 -98.7%
H
0.1
325
|
L
 -99.9%
H
0.1
3750
|
L
H
0.1
687487.5
|
Revolution Medicines Inc |
|
7,521.5
|
40.4
|
L
 -0.7%
H
40.2
41.2
|
L
 1.5%
H
36.5
41.5
|
L
 -0.8%
H
36.4
43.7
|
L
 -0.9%
H
29.2
43.7
|
L
 5.4%
H
29.2
62.4
|
L
 133.4%
H
15.5
62.4
|
L
 19.6%
H
14.1
62.4
|
L
H
14.1
62.4
|
Upexi Inc |
|
426.2
|
11.2
|
L
 -1.2%
H
10.8
11.3
|
L
 5.2%
H
9.2
12.0
|
L
 -20.1%
H
9.1
15.5
|
L
 251.3%
H
1.9
22.5
|
L
 1.2%
H
1.9
22.5
|
L
 -89.5%
H
1.9
121.6
|
L
H
1.9
187.4
|
L
H
1.9
187.4
|
Scinai Immunotherapeutics ... |
|
2.4
|
2.4
|
L
 -4%
H
2.3
2.6
|
L
 -13.0%
H
2.3
2.9
|
L
 -13.7%
H
2.3
3.0
|
L
 -32.2%
H
1.9
3.9
|
L
 -36%
H
1.9
8.9
|
L
 -98.2%
H
1.9
136
|
L
 -99.9%
H
1.9
6200
|
L
 -99.4%
H
1.9
6200
|
FitLife Brands Inc |
|
138.9
|
14.8
|
L
 -0.1%
H
14.2
14.8
|
L
 1.4%
H
14.2
15.3
|
L
 -6.2%
H
13.3
16.2
|
L
 -1.5%
H
9.8
16.2
|
L
 -51.8%
H
9.8
35.5
|
L
 -10.6%
H
9.8
35.5
|
L
 -10.6%
H
9.8
35.5
|
L
 -10.6%
H
9.8
35.5
|
Abivax - ADR |
|
457.4
|
7.2
|
L
 13.5%
H
6.4
7.4
|
L
 27.2%
H
5.6
7.4
|
L
 0.3%
H
5.6
7.4
|
L
 -6.1%
H
4.8
8.5
|
L
 -48.5%
H
4.8
14.7
|
L
H
4.8
17.0
|
L
H
4.8
17.0
|
L
H
4.8
17.0
|
Synergy CHC Corp |
|
15.6
|
1.7
|
L
 -1.7%
H
1.7
1.9
|
L
 -11.7%
H
1.7
2.0
|
L
 -18.8%
H
1.7
2.4
|
L
 -55.0%
H
1.3
4.1
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
iBio Inc |
|
13.7
|
0.8
|
L
 1.2%
H
0.8
0.8
|
L
 1.2%
H
0.8
0.8
|
L
 3.8%
H
0.8
0.9
|
L
 3.8%
H
0.8
0.9
|
L
 3.8%
H
0.8
0.9
|
L
 3.8%
H
0.8
0.9
|
L
 3.8%
H
0.8
0.9
|
L
 3.8%
H
0.8
0.9
|